Iovance Biotherapeutics Ownership | Who Owns Iovance Biotherapeutics?

Overview Forecast RevenueFinancials Chart Transcripts

Iovance Biotherapeutics Ownership Summary

Iovance Biotherapeutics is owned by 87.32% institutional investors, 0.53% insiders, and 12.15% retail investors. Vanguard group is the largest institutional shareholder, holding 9.75% of IOVA shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 2.87% of its assets in Iovance Biotherapeutics shares.

IOVA Ownership Benchmark

Type	Name	% Inst	% Insiders	% Retail
Stock	Iovance Biotherapeutics	87.32%	0.53%	12.15%
Sector	Healthcare Stocks	47.31%	8.01%	44.69%
Industry	Biotech Stocks	45.43%	7.81%	46.75%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

Holder	Shares	% Holding	Value
Vanguard group	25.95M	9.75%	$208.12M
Perceptive advisors	25.93M	9.74%	$207.98M
Mhr fund management	24.00M	9.01%	$192.46M
Blackrock	21.23M	7.97%	$170.23M
State street	12.63M	4.74%	$101.25M
Avoro capital advisors	11.70M	4.39%	$93.83M
Soleus capital management	7.55M	2.84%	$60.53M
Geode capital management	5.79M	2.17%	$46.42M
Artisan partners limited partnership	5.11M	1.92%	$40.99M
Balyasny asset management	4.54M	1.71%	$36.42M

Top Institutional Shareholders by % of Total Assets

Holder	Shares	% Assets	Value
Mhr fund management	24.00M	23.45%	$192.46M
Soleus capital management	7.55M	5.34%	$60.53M
Perceptive advisors	25.93M	4.94%	$207.98M
Bioimpact capital	2.37M	2.95%	$18.98M
Parametrica management	261.09K	2.77%	$2.09M
Orion investment	794.70K	2.54%	$6.37M
Palo alto investors lp	2.12M	1.97%	$16.97M
Cm management	250.00K	1.84%	$2.00M
Long focus capital management	4.13M	1.27%	$33.14M
Avoro capital advisors	11.70M	1.25%	$93.83M

Top Buyers

Holder	Shares	% Assets	Change
Perceptive advisors	25.93M	4.94%	6.66M
Soleus capital management	7.55M	5.34%	4.04M
Balyasny asset management	4.54M	0.06%	3.34M
Long focus capital management	4.13M	1.27%	2.73M
State street	12.63M	0.00%	2.22M

Top Sellers

Holder	Shares	% Assets	Change
Pictet asset management sa	920.08K	0.01%	-2.33M
Price t rowe associates inc /md/	3.48M	0.00%	-1.79M
Marshall wace, llp	-	-	-1.61M
Summit partners public asset management	-	-	-1.56M
Woodline partners lp	-	-	-1.48M

New Positions

Holder	Shares	% Assets	Change	Value
Artal group	1.01M	0.21%	1.01M	$8.11M
Norges bank	942.98K	0.00%	942.98K	$7.56M
Orion investment	794.70K	2.54%	794.70K	$6.37M
Two sigma investments, lp	774.78K	0.01%	774.78K	$6.21M
Capital fund management	383.26K	0.01%	383.26K	$3.07M

Sold Out

Holder	Change
Massmutual trust co fsb/adv	-28.00
Cibc private wealth group	-35.00
Nelson, van denburg & campbell wealth management group	-46.00
Sound income strategies	-50.00
Fifth third bancorp	-62.00

Institutional Ownership Trends

Date	Holdings	Change %	Shares	Change %	Ownership	Change %	Increased Position	Change %	Decreased Position	Change %
Jun 30, 2024	305	2.69%	232,471,450	7.59%	87	1.23%	177	9.94%	82	-6.82%
Mar 31, 2024	297	18.33%	216,063,214	4.25%	84	1.19%	161	13.38%	88	31.34%
Dec 31, 2023	251	1.21%	207,248,234	-2.24%	84	0.95%	142	-2.74%	67	21.82%
Sep 30, 2023	248	7.83%	212,001,334	3.96%	94	1.04%	146	18.70%	55	-15.38%
Jun 30, 2023	230	-3.36%	203,926,047	-0.71%	95	1.03%	123	-1.60%	65	-2.99%

Top Mutual Funds Shareholders

Holder	Shares	% Holding	Change
Vanguard Total Stock Mkt Idx Inv	8.71M	2.87%	762.45K
SPDR® S&P Biotech ETF	7.20M	2.37%	79.69K
Vanguard Small Cap Index	6.83M	2.25%	453.35K
iShares Russell 2000 ETF	6.53M	2.14%	-14.67K
Vanguard Small Cap Value Index Inv	4.63M	1.53%	355.96K
Vanguard Institutional Extnd Mkt Idx Tr	3.38M	1.11%	-362.59K
Delaware Small Cap Core I	2.61M	0.86%	1.84M
Fidelity Small Cap Index	2.59M	0.85%	-63.86K
iShares Russell 2000 Growth ETF	2.26M	0.74%	-
Artisan U.S. Small-Cap Growth	2.03M	0.67%	-390.13K

Recent Insider Transactions

Date	Name	Role	Activity	Value
Nov 12, 2024	Maynard Ryan D	-	Sell	$503.00K
Feb 20, 2024	MCPEAK MERRILL A	-	Buy	$2.29M
Feb 20, 2024	Dukes Iain D.	-	Buy	$292.80K
Feb 20, 2024	Rothbaum Wayne P.	-	Buy	$45.75M
Sep 18, 2023	MCPEAK MERRILL A	-	Buy	$55.60K

Insider Transactions Trends

Date	Buy	Sell
2024 Q4	-	1
2024 Q3	-	-
2024 Q2	-	-
2024 Q1	3	-
2023 Q4	-	-

IOVA Ownership FAQ

Who Owns Iovance Biotherapeutics?

Iovance Biotherapeutics shareholders are primarily institutional investors at 87.32%, followed by 0.53% insiders and 12.15% retail investors. The average institutional ownership in Iovance Biotherapeutics's industry, Biotech Stocks , is 45.43%, which Iovance Biotherapeutics exceeds.

Who owns the most shares of Iovance Biotherapeutics?

Iovance Biotherapeutics’s largest shareholders are Vanguard group (25.95M shares, 9.75%), Perceptive advisors (25.93M shares, 9.74%), and Mhr fund management (24M shares, 9.01%). Together, they hold 28.50% of Iovance Biotherapeutics’s total shares outstanding.

Does Blackrock own Iovance Biotherapeutics?

Yes, BlackRock owns 7.97% of Iovance Biotherapeutics, totaling 21.23M shares as of Jun 2024. This represents 0.00% of BlackRock's total assets, with a market value of 170.23M$. In the last quarter, BlackRock increased its holdings by 1.3M shares, a 6.50% change.

Who is Iovance Biotherapeutics’s biggest shareholder by percentage of total assets invested?

Mhr fund management is Iovance Biotherapeutics’s biggest shareholder by percentage of total assets invested, with 23.45% of its assets in 24M Iovance Biotherapeutics shares, valued at 192.46M$.

Who is the top mutual fund holder of Iovance Biotherapeutics shares?

Vanguard Total Stock Mkt Idx Inv is the top mutual fund holder of Iovance Biotherapeutics shares, with 2.87% of its total shares outstanding invested in 8.71M Iovance Biotherapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis

Discover trending investment themes
Find your next best investment
Research stocks using tools